The relevance of pneumococcal serotypes

Current Infectious Disease Reports

Volumn 16, Issue 4, 2014, Pages

  Rodrigo, Chamira ^a   Lim, Wei Shen ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Disease severity; Invasive; Mortality; Pneumococcal; Serotype; Streptococcus pneumoniae; Vaccine

Indexed keywords

ANTIBIOTIC AGENT; PNEUMOCOCCUS VACCINE;

AGING; ANTIBIOTIC RESISTANCE; ARTICLE; DISEASE SEVERITY; HEALTH CARE COST; HOST; HUMAN; IMMUNITY; IMMUNIZATION; MENINGITIS; MORBIDITY; MORTALITY; NONHUMAN; PARAPNEUMONIC EFFUSION; PNEUMOCOCCAL INFECTION; PNEUMONIA; RESPIRATORY TRACT DISEASE; SEROEPIDEMIOLOGY; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 84896415549     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-014-0403-3     Document Type: Article

References (86)

1. • O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374(9693):893-902. doi:10.1016/s0140-6736(09) 61204-6. This article illustrates the magnitude of the pneumococcal disease burden in children, both worldwide and at a regional level.
2. Ewig S, Birkner N, Strauss R, Schaefer E, Pauletzki J, Bischoff H, et al. New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax. 2009;64: 1062-9. doi:10.1136/thx.2008.109785.
3. Rodrigo C, Mckeever TM, Woodhead M, Lim WS, on behalf of the British Thoracic Society. Single versus combination antibiotic therapy in adults hospitalised with community acquired pneumonia. Thorax. 2013;68(5):493-5. doi:10.1136/thoraxjnl-2012-202296.
4. Trotter CL, Stuart JM, George R, Miller E. Increasing hospital admissions for pneumonia, England. Emerg Infect Dis. 2008;14(5):727-33. (Pubitemid 351838635)
5. Cillóniz C, Ewig S, Polverino E, Marcos MA, Esquinas C, Gabarrús A, et al. Microbial aetiology of community-acquired pneumonia and its relation to severity. Thorax. 2011;66:340-6. doi:10.1136/thx.2010. 143982.
6. Weycker D, Strutton D, Edelsberg J, Sato R, Jackson LA. Clinical and economic burden of pneumococcal disease in older US adults. Vaccine. 2010;28(31):4955-60. doi:10.1016/j.vaccine.2010.05.030.
7. Wroe PC, Finkelstein JA, Ray GT, Linder JA, Johnson KM, Rifas-Shiman S, et al. Aging population and future burden of pneumococcal pneumonia in the United States. J Infect Dis. 2012;205(10): 1589-92. doi:10.1093/infdis/jis240.
8. Bogaert D, deGroot R, Hermans PWM. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis. 2004;4(3):144-54. doi:10.1016/s1473-3099(04)00938-7. (Pubitemid 38293138)
9. Garcia-Rodriguez JA, Fresnadillo Martinez MJ. Dynamics of nasopharyngeal colonization by potential respiratory pathogens. J Antimicrob Chemother. 2002;50(Suppl S2):59-73.
10. Henriques-Normark B, Tuomanen EI. The pneumococcus: epidemiology, microbiology, and pathogenesis. Cold Spring Harbor Perspect Med. 2013;3(7). doi:10.1101/cshperspect.a010215.
11. Hussain M, Melegaro A, Pebody RG, George R, Edmunds WJ, Talukdar R, et al. A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting. Epidemiol Infect. 2005;133:891-8. doi:10.1017/ S0950268805004012. (Pubitemid 41478975)
12. Regev-Yochay G, Dagan R, Raz M, Carmeli Y, Shainberg B, Derazne E, et al. Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in children. JAMA. 2004;292(6):716-20. doi:10.1001/jama.292.6.716. (Pubitemid 39062526)
13. Hill PC, Townend J, Antonio M, Akisanya B, Ebruke C, Lahai G, et al. Transmission of Streptococcus pneumoniae in rural Gambian villages: a longitudinal study. Clin Infect Dis. 2010;50(11):1468-76. doi:10.1086/652443.
14. Mueller JE, Yaro S, Ouédraogo MS, Levina N, Njanpop-Lafourcade B-M, Tall H, et al. Pneumococci in the African meningitis belt: meningitis incidence and carriage prevalence in children and adults. PLoS One. 2012;7(12):e52464. doi:10.1371/journal.pone.0052464.
15. Nuorti JP, Butler JC, Farley MM, Harrison LH, McGeer A, Kolczak MS, et al. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med. 2000;342(10):681-9. (Pubitemid 30131420)
16. Rodrigo C, Bewick T, Sheppard C, Greenwood S, MacGregor V, Trotter C, et al. Pneumococcal serotypes in adult non-invasive and invasive pneumonia in relation to child contact and child vaccination status. Thorax. 2014;69(2):168-73. doi:10.1136/thoraxjnl-2013-203987.
17. Abeyta M, Hardy GG, Yother J. Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae. Infect Immun. 2003;71(1):218-25. doi:10.1128/iai.71.1.218-225.2003. (Pubitemid 36026023)
18. Nelson AL, Roche AM, Gould JM, Chim K, Ratner AJ,Weiser JN. Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance. Infect Immun. 2007;75(1):83-90. doi:10.1128/iai.01475-06. (Pubitemid 46047881)
19. • van der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet. 2009;374(9700):1543-56. doi:10.1016/s0140- 6736(09)61114-4. This article provides an overview of the immunopathology of the pneumococcus, including the role of the polysaccharide capsule.
20. Wartha F, Beiter K, Albiger B, Fernebro J, Zychlinsky A, Normark S, et al. Capsule and D-alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps. Cell Microbiol. 2007;9(5):1162-71. doi:10.1111/j.1462-5822.2006.00857.x. (Pubitemid 46547136)
21. Calix JJ, Dagan R, Pelton SI, Porat N, Nahm MH. Differential occurrence of Streptococcus pneumoniae serotype 11E between asymptomatic carriage and invasive pneumococcal disease isolates reflects a unique model of pathogen microevolution. Clin Infect Dis. 2012;54(6):794-9.
22. • Johnson HL, Deloria-Knoll M, Levine OS, Stoszek SK, Freimanis Hance L, Reithinger R, et al. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med. 2010;7(10): e1000348. doi:10.1371/journal.pmed. 1000348. A systematic review of pneumococcal serotype distribution, globally and regionally, in children with invasive pneumococcal disease.
23. Miller E, Andrews NJ, Waight PA, Slack MPE, George RC. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis. 2011;11(10):760-8.
24. Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis. 2010;201(1):32-41.
25. van Deursen AM, van Mens SP, Sanders EA, Vlaminckx BJ, de Melker HE, Schouls LM, et al. Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands. Emerg Infect Dis. 2012;18(11):1729-37. doi:10.3201/eid1811.120329.
26. Ben-Shimol S, Greenberg D, Givon-Lavi N, Elias N, Glikman D, Rubinstein U, et al. Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel. Vaccine. 2012;30(46):6600-7. doi:10.1016/j.vaccine.2012.08.012.
27. Fitzgerald T, Massey PD, Islam F. Changes in invasive pneumococcal disease serotypes in a regional area of Australia following three years of 7vPCV introduction. West Pac Surveill Response J. 2012;3(2):33-8.
28. Ardanuy C, Tubau F, Pallares R, Calatayud L, Domínguez MA, Rolo D, et al. Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007. Clin Infect Dis. 2009;48(1):57-64. doi:10.1086/594125.
29. dos Santos SR, Passadore LF, Takagi EH, Fujii CM, Yoshioka CRM, Gilio AE, et al. Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation. Vaccine. 2013;31(51):6150-4. doi:10.1016/j.vaccine.2013.05.042.
30. Huang SS, Hinrichsen VL, Stevenson AE, Rifas-Shiman SL, Kleinman K, Pelton SI, et al. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics. 2009;124(1):e1-e11. doi:10.1542/peds.2008-3099.
31. Millar EV, Watt JP, Bronsdon MA, Dallas J, Reid R, Santosham M, et al. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members. Clin Infect Dis. 2008;47(8):989-96. doi:10.1086/591966.
32. Malley R, Lipsitch M, Stack A, Saladino R, Fleisher G, Pelton S, et al. Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci. Infect Immun. 2001;69(8):4870-3. doi:10.1128/iai.69.8.4870-4873.2001. (Pubitemid 32674467)
33. Morona JK, Morona R, Paton JC. Attachment of capsular polysaccharide to the cell wall of Streptococcus pneumoniae type 2 is required for invasive disease. Proc Natl Acad Sci U S A. 2006;103(22):8505-10. doi:10.1073/pnas. 0602148103. (Pubitemid 43838485)
34. Kadioglu A, Weiser JN, Paton JC, Andrew PW. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nature. 2008;6:288-301. (Pubitemid 351404773)
35. Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, Spratt BG. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis. 2003;187(9):1424-32. doi:10.1086/374624. (Pubitemid 36549688)
36. Hanage WP, Kaijalainen TH, Syrjanen RK, Auranen K, Leinonen M, Makela PH, et al. Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland. Infect Immun. 2005;73(1):431-5. doi:10.1128/iai.73.1.431- 435.2005. (Pubitemid 40041136)
37. Sa-Leao R, Pinto F, Aguiar S, Nunes S, Carrico JA, Frazao N, et al. Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype. J Clin Microbiol. 2011;49(4):1369-75. doi:10.1128/jcm.01763-10.
38. Sleeman KL, Griffiths D, Shackley F, Diggle L, Gupta S, Maiden MC, et al. Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. J Infect Dis. 2006;194(5):682-8. doi:10.1086/505710. (Pubitemid 44297855)
39. Burgos J, Luján M, Larrosa MN, Fontanals D, Bermudo G, Planes AM, et al. Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes. Eur Respir J. 2014;43(2):545-53. doi:10.1183/09031936.00050413.
40. Alanee SR, McGee L, Jackson D, Chiou CC, Feldman C, Morris AJ, et al. Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study. Clin Infect Dis. 2007;45(1):46-51. doi:10.1086/518538. (Pubitemid 46984614)
41. Garcia-Vidal C, Ardanuy C, Tubau F, Viasus D, Dorca J, Linares J, et al. Pneumococcal pneumonia presenting with septic shock: hostand pathogen-related factors and outcomes. Thorax. 2010;65(1):77-81. doi:10.1136/thx.2009.123612.
42. Burgos J, Falcó V, Borrego A, Sordé R, Larrosa MN, Martinez X, et al. Impact of the emergence of non-vaccine pneumococcal serotypes on the clinical presentation and outcome of adults with invasive pneumococcal pneumonia. Clin Microbiol Infect. 2013;19(4):385-91. doi:10.1111/j.1469-0691. 2012.03895.x.
43. Bender JM, Ampofo K, Korgenski K, Daly J, Pavia AT, Mason EO, et al. Pneumococcal necrotizing pneumonia in Utah: does serotype matter? Clin Infect Dis. 2008;46(9): 1346-52. doi:10.1086/586747. (Pubitemid 351589931)
44. Sjöström K, Spindler C, Ortqvist A, Kalin M, Sandgren A, Kühlmann-Berenzon S, et al. Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen. Clin Infect Dis. 2006;42(4):451-9. doi:10.1086/499242. (Pubitemid 43202515)
45. • Weinberger DM, Harboe ZB, Sanders EAM, Ndiritu M, Klugman KP, Rückinger S, et al. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis. 2010;51(6):692-9. doi:10.1086/655828. A systematic review and meta-analysis of serotype-specific risk of death in invasive pneumococcal disease.
46. Weinberger DM, Trzciński K, Lu Y-J, Bogaert D, Brandes A, Galagan J, et al. Pneumococcal capsular polysaccharide structure predicts serotype prevalence. PLoS Pathog. 2009;5(6):e1000476. doi:10.1371/journal.ppat.1000476.
47. Moberley S, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev. 2013;1:CD000422. doi:10.1002/14651858.CD000422.pub3.
48. Robbins JB, Austrian R, Lee C-J, Rastogi SC, Schiffman G, Henrichsen J, et al. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis. 1983;148(6):1136-59. doi:10.1093/infdis/148.6.1136. (Pubitemid 14206325)
49. McCool TL, Harding CV, Greenspan NS, Schreiber JR. B- and Tcell immune responses to pneumococcal conjugate vaccines: divergence between carrier- and polysaccharide-specific immunogenicity. Infect Immun. 1999;67(9):4862-9. (Pubitemid 29400475)
50. Malley R, Trzcinski K, Srivastava A, Thompson CM, Anderson PW, Lipsitch M. CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc Natl Acad Sci U S A. 2005;102(13):4848-53. doi:10.1073/pnas.0501254102. (Pubitemid 40471542)
51. Centers for Disease Control and Prevention. Progress in introduction of pneumococcal conjugate vaccine - worldwide, 2000-2012. MMWR Morb Mortal Wkly Rep. 2013;62(16):308-11.
52. Hammitt LL, Bruden DL, Butler JC, Baggett HC, Hurlburt DA, Reasonover A, et al. Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease. J Infect Dis. 2006;193(11):1487-94. doi:10.1086/503805. (Pubitemid 43794576)
53. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348(18):1737-46. (Pubitemid 36514704)
54. Griffin MR, Zhu Y, Moore MR, Whitney CG, Grijalva CG. U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination. N Engl J Med. 2013;369(2):155-63.
55. Vestrheim DF, Lovoll O, Aaberge IS, Caugant DA, Hoiby EA, Bakke H, et al. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway. Vaccine. 2008;26(26):3277-81. doi:10.1016/j.vaccine.2008.03.087.
56. Liesenborghs L, Verhaegen J, Peetermans WE, Vandeven J, Flamaing J. Trends in serotype prevalence in invasive pneumococcal disease before and after infant pneumococcal vaccination in Belgium, 2002-2010. Vaccine. 2013;31(11):1529-34. doi:10.1016/ j.vaccine.2012.11.103.
57. Ansaldi F, de Florentiis D, Canepa P, Zancolli M, Martini M, Orsi A, et al. Carriage of Streptoccoccus pneumoniae 7 years after implementation of vaccination program in a population with very high and long-lasting coverage, Italy. Vaccine. 2012;30(13):2288-94. doi:10.1016/j.vaccine.2012.01.067.
58. Sharma D, BaughmanW, Holst A, Thomas S, Jackson D, da Gloria Carvalho M, et al. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine. Pediatr Infect Dis J. 2013;32(2):e45-53. doi:10.1097/INF.0b013e3182788fdd.
59. Flasche S, Van Hoek AJ, Sheasby E, Waight P, Andrews N, Sheppard C, et al. Effect of Pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study. PLoS Med. 2011;8(4):e1001017. doi:10.1371/journal.pmed.1001017.
60. Nurhonen M, Cheng AC, Auranen K. Pneumococcal transmission and disease in silico: amicrosimulationmodel of the indirect effects of vaccination. PLoS One. 2013;8(2):e56079. doi:10.1371/journal.pone.0056079.
61. Said MA, Johnson HL, Nonyane BAS, Deloria-Knoll M, O'Brien KL, for the AAPBST. Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques. PLoS One. 2013;8(4):e60273.
62. Bewick T, Sheppard C, Greenwood S, Slack M, Trotter C, George R, et al. Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia. Thorax. 2012;67(6):540-5.
63. Cillóniz C, Ewig S, Polverino E, Muñoz-Almagro C, Marco F, Gabarrús A, et al. Pulmonary complications of pneumococcal community-acquired pneumonia: incidence, predictors, and outcomes. Clin Microbiol Infect. 2012;18(11):1134-42. doi:10.1111/j.1469-0691.2011.03692.x.
64. Sherwin RL, Gray S, Alexander R, McGovern PC, Graepel J, Pride MW, et al. Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged ≥50 years with community-acquired pneumonia. J Infect Dis.2013;208(11):1813-20. doi:10.1093/infdis/jit506.
65. Sahn SA. Diagnosis and management of parapneumonic effusions and empyema. Clin Infect Dis. 2007;45(11):1480-6. doi:10.1086/522996. (Pubitemid 351411880)
66. Hasley PB, Albaum MN, Li YH, Fuhrman CR, Britton CA,Marrie TJ, et al. Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquired pneumonia? Arch Intern Med. 1996;156(19):2206-12. (Pubitemid 26361913)
67. Maskell NA, Batt S, Hedley EL, Davies CWH, Gillespie SH, Davies RJO. The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am J Respir Crit Care Med. 2006;174(7):817-23. doi:10.1164/rccm.200601-074OC. (Pubitemid 44511664)
68. Thomas M, Simmister C, Elemraid M, Clark J, Rushton S, Gorton R, et al. The UK-ESPE study: paediatric empyema in the UK. Arch Dis Child. 2012;97 Suppl 1:A20- 1. doi:10.1136/archdischild-2012-301885.52.
69. Yu J, Salamon D, Marcon M, Nahm MH. Pneumococcal serotypes causing pneumoniawith pleural effusion in pediatric patients. J Clin Microbiol. 2011;49(2):534-8. doi:10.1128/jcm.01827-10.
70. Obando I, Camacho-Lovillo MS, Porras A, Gandia-Gonzalez MA, Molinos A, Vazquez-Barba I, et al. Sustained high prevalence of pneumococcal serotype 1 in paediatric parapneumonic empyema in southern Spain from 2005 to 2009. Clin Microbiol Infect. 2012;18(8):763-8. doi:10.1111/j.1469-0691.2011.03632.x.
71. Bewick T, Sheppard C, Greenwood S, Slack M, Trotter C, George R, et al. Serotypes associated with the development of pneumococcal para-pneumonic effusion in adults. Eur Respir J. 2013;42(3): 733-41. doi:10.1183/09031936. 00144712.
72. Grijalva CG, Nuorti JP, Zhu Y, Griffin MR. Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States. Clin Infect Dis. 2010;50(6):805-13. doi:10.1086/650573.
73. Calbo E, Díaz Á, Cañadell E, Fábrega J, Uriz S, Xercavins M, et al. Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine. Clin Microbiol Infect. 2006;12(9):867-72. doi:10.1111/j.1469-0691.2006.1502-1.x. (Pubitemid 44151286)
74. Koshy E, Murray J, Bottle A, Sharland M, Saxena S. Impact of the seven-valent pneumococcal conjugate vaccination (PCV7) programme on childhood hospital admissions for bacterial pneumonia and empyema in England: national time-trends study, 1997-2008. Thorax. 2010;65(9):770- 4. doi:10.1136/thx.2010. 137802.
75. Avci FY, Kasper DL. How bacterial carbohydrates influence the adaptive immune system. Annu Rev Immunol. 2010;28:107-30. doi:10.1146/annurev-immunol- 030409-101159.
76. Tzianabos AO, Onderdonk AB, Rosner B, Cisneros RL, Kasper DL. Structural features of polysaccharides that induce intraabdominal abscesses. Science. 1993;262(5132):416-9. (Pubitemid 23353382)
77. Hsu HE, Shutt KA,Moore MR, Beall BW, Bennett NM, Craig AS, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med. 2009;360(3):244-56. doi:10.1056/NEJMoa0800836.
78. Gessner BD, Mueller JE, Yaro S. African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults. BMC Infect Dis. 2010;10:22. doi:10.1186/1471-2334-10-22.
79. Kim SH, Song J-H, Chung DR, Thamlikitkul V, Yang Y, Wang H, et al. Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study. Antimicrob Agents Chemother. 2012;56(3):1418-26. doi:10.1128/aac.05658-11.
80. Rodríguez MAG, González AV, Gavín MAO, Martínez FM, Marín NG, Blázquez BR, et al. Invasive pneumococcal disease: association between serotype, clinical presentation and lethality. Vaccine. 2011;29(34):5740-6. doi:10.1016/j.vaccine.2011.05.099.
81. • Kaplan SL, Barson WJ, Lin PL, Stovall SH, Bradley JS, Tan TQ, et al. Serotype 19A is the most common serotype causing invasive pneumococcal infections in children. Pediatrics. 2010;125(3):429-36. doi:10.1542/peds.2008- 1702. This article highlights the significance of serotype 19A as an important ' replacement' serotype, and its role in antimicrobial resistance.
82. Beall BW, Gertz RE, Hulkower RL, Whitney CG, Moore MR, Brueggemann AB. Shifting genetic structure of invasive serotype 19A pneumococci in the United States. J Infect Dis. 2011;203(10): 1360-8. doi:10.1093/infdis/jir052.
83. Hulten KG, Kaplan SL, Lamberth LB, Barson WJ, Romero JR, Lin PL, et al. Changes in Streptococcus pneumoniae serotype 19A invasive infections in children from 1993 to 2011. J Clin Microbiol. 2013;51(4):1294-7. doi:10.1128/jcm.00058- 13.
84. Choi EH, Kim SH, Eun BW, Kim SJ, Kim NH, Lee J, et al. Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg Infect Dis. 2008;14(2):275-81. doi:10.3201/eid1402.070807. (Pubitemid 351213678)
85. Green MC, Mason EO, Kaplan SL, Lamberth LB, Stovall SH, Givner LB, et al. Increase in prevalence of Streptococcus pneumoniae serotype 6C at eight children's hospitals in the United States from 1993 to 2009. J Clin Microbiol. 2011;49(6): 2097-101. doi:10.1128/jcm.02207-10.
86. Ko KS, Baek JY, Song JH. Multidrug-resistant Streptococcus pneumoniae serotype 6D clones in South Korea. J Clin Microbiol. 2012;50(3):818-22. doi:10.1128/jcm.05895-11.